Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots acquired 6 shares of the company’s stock in a transaction on Monday, August 11th. The shares were acquired at an average price of GBX 2,539 ($34.35) per share, for a total transaction of £152.34 ($206.12).
Steve Foots also recently made the following trade(s):
- On Monday, August 4th, Steve Foots bought 3,815 shares of Croda International stock. The shares were acquired at an average price of GBX 2,617 ($35.41) per share, with a total value of £99,838.55 ($135,081.25).
- On Tuesday, July 15th, Steve Foots purchased 5 shares of Croda International stock. The stock was bought at an average price of GBX 2,987 ($40.41) per share, with a total value of £149.35 ($202.07).
Croda International Stock Performance
Shares of CRDA opened at GBX 2,483 ($33.59) on Friday. The stock has a market capitalization of £3.47 billion, a PE ratio of 21.34, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The business’s fifty day moving average price is GBX 2,876.66 and its 200 day moving average price is GBX 2,980.40. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. Croda International Plc has a 12-month low of GBX 2,426.77 ($32.83) and a 12-month high of GBX 4,335 ($58.65).
Analyst Ratings Changes
A number of research firms have commented on CRDA. Berenberg Bank reduced their price objective on shares of Croda International from GBX 3,800 ($51.41) to GBX 3,100 ($41.94) and set a “buy” rating on the stock in a research note on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Croda International from GBX 3,400 ($46.00) to GBX 3,000 ($40.59) and set a “hold” rating on the stock in a research report on Tuesday, July 29th. Citigroup decreased their price target on Croda International from GBX 3,550 ($48.03) to GBX 3,300 ($44.65) and set a “neutral” rating for the company in a research note on Tuesday, April 29th. Finally, JPMorgan Chase & Co. upgraded Croda International to an “overweight” rating in a research note on Wednesday, July 30th.
Check Out Our Latest Analysis on Croda International
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Featured Articles
- Five stocks we like better than Croda International
- What is a Microcap Stock? Everything You Need to Know
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- What is the FTSE 100 index?
- Deere’s Sell-Off Could Be a Long-Term Buying Chance
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.